greeksoup/ stock research
Stock research / United States / EW / FY2008

Edwards Lifesciences (EW) FY2008 results: revenue $1.2 billion

Edwards Lifesciences Corp. (EW) reported revenue of $1.2 billion for fiscal 2008, the year ended 31 December 2008. Net income was $129 million, and diluted earnings per share $0.18. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2011.

Revenue
$1.2 billion
FY2008FY2008
Operating margin
n/a
FY2008FY2008
Net income
$129 million
FY2008FY2008
Diluted EPS
$0.18
FY2008FY2008

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2008Last 8 years
Revenue1,238
Cost of revenue420
Gross profit818
Gross margin66.1%
Research and development139
Selling, general and administrative481
Interest expense7.2
Pre-tax income164
Income tax35.5
Effective tax rate21.6%
Net income129
Net margin10.4%
Diluted EPS$0.18
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2008Last 8 years
Operating cash flow153
Capital expenditure50.6
Free cash flow103
Free cash flow margin8.3%
Cash from investing58.8
Cash from financing-134
Depreciation and amortisation55.6
Share-based compensation28.7
Buybacks306
Diluted shares, weighted715m

Balance sheet

$ millionFY2008Last 8 years
Shareholders' equity879
Goodwill316
Cash and equivalents219

10-K for the year ended 31 December 2008, filed 28 February 2011: the filing.